“Canaccord Predicts Over 100% Rally for These 3 “Strong Buy” Stocks”
October 16, 2020
“Zynerba Pharmaceuticals (ZYNE)…
Turning to the rest of the Street, the bulls have it on this one. With 3 Buys and a lone Hold, the word on the Street is that ZYNE is a Strong Buy. At $13, the average price target implies 245% upside potential…
Atreca (BCEL)…
All in all, other analysts are on the same page. 3 Buys and no Holds or Sells add up to a Strong Buy consensus rating. With an average price target of $28.67, the upside potential comes in at 91%…
Cara Therapeutics (CARA)…
Are other analysts in agreement? They are. Only Buy ratings have been issued in the last three months. Therefore, the consensus is unanimous: CARA is a Strong Buy. Given the $32.67 average price target, shares could climb 118.5% in the next year…”
https://finance.yahoo.com/news/canaccord-predicts-over-100-rally-150126313.html